Quest Diagnostics Inc (DGX) Com Stk Usd0.01

Sell:$211.87Buy:$211.90Price increased$0.81 (0.38%)

Prices delayed by at least 15 minutes
Sell:$211.87
Buy:$211.90
Change:Price increased$0.81 (0.38%)
Prices delayed by at least 15 minutes
Sell:$211.87
Buy:$211.90
Change:Price increased$0.81 (0.38%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 February 2026
Catherine T DohertyExecutive Vice President
Sell
Regular sell transaction (market)
1,433$204.83$293,521.3968,402
19 February 2026
Michael E PrevoznikGeneral Counsel
Sell
Regular sell transaction (market)
1,111$204.83$227,566.1338,371
19 February 2026
Patrick T PlewmanSenior Vice President
Sell
Regular sell transaction (market)
958$204.83$196,227.1415,838
18 February 2026
James E. DavisChairman/CEO
Sell
Tax related
2,396$210.01$503,183.96133,941
18 February 2026
James E. DavisChairman/CEO
Sell
Tax related
3,788$206.99$784,078.12130,153
18 February 2026
Catherine T DohertyExecutive Vice President
Sell
Tax related
433$210.01$90,934.3370,563
18 February 2026
Catherine T DohertyExecutive Vice President
Sell
Tax related
728$206.99$150,688.7269,835
18 February 2026
Michael E PrevoznikGeneral Counsel
Sell
Tax related
301$210.01$63,213.0139,829
18 February 2026
Michael E PrevoznikGeneral Counsel
Sell
Tax related
347$206.99$71,825.5339,482
18 February 2026
Michael J DeppeChief Accounting Officer
Sell
Tax related
83$210.01$17,430.8334,659

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
25 November 2025
James E. DavisChairman/CEO
Sell
Option/Award related
41,004$192.27$7,883,900.59125,227
4 March 2025
James E. DavisChairman/CEO
Sell
Tax related
31,656$173.74$5,499,913.44166,814
23 September 2025
Michael E PrevoznikGeneral Counsel
Sell
Option/Award related
28,288$187.12$5,293,312.7938,117
13 February 2026
Catherine T DohertyExecutive Vice President
Sell
Option/Award related
10,573$205.21$2,169,655.7383,660
13 February 2026
Catherine T DohertyExecutive Vice President
Sell
Option/Award related
10,122$206.37$2,088,883.2173,538

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.